Skip to Content
Get key facts and figures about chronic dry eye

Ketotifen ophthalmic Pregnancy and Breastfeeding Warnings

Ketotifen ophthalmic is also known as: Alaway, Claritin Eye, Eye Itch Relief, Refresh Eye Itch Relief, Visine All Day Eye Itch Relief, Zaditor, Zyrtec Itchy Eye Drops

Ketotifen ophthalmic Pregnancy Warnings

Animal studies have revealed evidence of pre- and postnatal mortality, including a slight decrease in body weight gain in the first four days after birth, when maternally toxic oral doses of 50 mg/kg/day were administered. These studies have not revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Fertility studies have revealed a trend for a decrease in male fertility when male rats were administered daily doses of greater than or equal to 2 mg/kg/day. AU TGA pregnancy category B1: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have not shown evidence of an increased occurrence of fetal damage.

Caution is recommended; this drug should be used during pregnancy only if the benefit to the mother outweighs the risk to the fetus. AU TGA pregnancy category: B1 US FDA pregnancy category: Not assigned

See references

Ketotifen ophthalmic Breastfeeding Warnings

Animal studies have revealed excretion of this drug into maternal milk following oral administration, however, it is unknown whether topical ophthalmic administration results in excretion into human breast milk.

Use is considered acceptable; caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Yes Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Zaditor (ketotifen ophthalmic)" Ciba Vision Ophthalmics, Duluth, GA.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  2. "Product Information. Zaditor (ketotifen ophthalmic)" Ciba Vision Ophthalmics, Duluth, GA.
  3. Cerner Multum, Inc. "Australian Product Information." O 0
  4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide